Mr Sake van der Wall
Spaarne Gasthuis, Haarlem (Netherlands (The))
Evaluation of appropriate use and clinical outcomes of idarucizumab as antidote of dabigatran in daily clinical practice
Event: ESC Congress 2018
Topic: Oral Anticoagulation
Session: Atrial fibrillation - Stroke prevention
ESC 365 is supported by
